CSIMarket
 


Anixa Biosciences Inc   (ANIX)
Other Ticker:  
 
 

ANIX's Capital Expenditures Growth by Quarter and Year

Anixa Biosciences Inc 's Capital Expenditures results by quarter and year




ANIX Capital Expenditures (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter October - 0.00 0.00 0.00
III Quarter July - 0.00 0.00 0.00
II Quarter April - 0.00 0.00 0.00
I Quarter January 0.00 0.00 0.00 0.00
FY   0.00 0.00 0.00 0.00



ANIX Capital Expenditures first quarter 2024 Y/Y Growth Comment
Anixa Biosciences Inc in the first quarter 2024 recorded Capital Expenditures of $ 0.00 millions.

According to the results reported in the first quarter 2024, Anixa Biosciences Inc achieved the best Capital Expenditures growth in Major Pharmaceutical Preparations industry. While Anixa Biosciences Inc ' s Capital Expenditures no change of % ranks overall at the positon no. in the first quarter 2024.




ANIX Capital Expenditures ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter October - - - -
III Quarter July - - - -
II Quarter April - - - -
I Quarter January - - - -
FY   - - - -

Financial Statements
Anixa Biosciences Inc 's first quarter 2024 Capital Expenditures $ 0.00 millions ANIX's Income Statement
Anixa Biosciences Inc 's first quarter 2023 Capital Expenditures $ 0.00 millions Quarterly ANIX's Income Statement
New: More ANIX's historic Capital Expenditures Growth >>


ANIX Capital Expenditures (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter October - - - -
III Quarter July - - - -
II Quarter April - - - -
I Quarter January - - - -
FY (Year on Year)   - - - -




Capital Expenditures first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Capital Expenditures first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Capital Expenditures by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Anixa Biosciences Inc 's Q/Q Capital Expenditures Growth


Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ANIX's I. Quarter Q/Q Capital Expenditures Comment


Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Capital Expenditures Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ANIX's I. Quarter Q/Q Capital Expenditures Comment


Anixa Biosciences Inc 's 12 Months Capital Expenditures Growth Year on Year


Capital Expenditures TTM Growth

12 Months Ending
(Jan 31 2024)
12 Months Ending
(Jul 31 2023)
12 Months Ending
(Apr 30 2023)
12 Months Ending
(Jan 31 2023)
12 Months Ending
(Oct 31 2022)
Cumulative Capital Expenditures 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Capital Expenditures Growth (TTM) - - - - -
Year on Year Capital Expenditures Growth Overall Ranking # # # # #
Seqeuential Capital Expenditures Change (TTM) - - - - -
Seq. Capital Expenditures Growth (TTM) Overall Ranking # # # # #




Cumulative Capital Expenditures growth Comment
In the Jan 31 2024 period, Anixa Biosciences Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Anixa Biosciences Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Capital Expenditures growth Comment
In the Jan 31 2024 period, Anixa Biosciences Inc 's cumulative trailing twelve month Capital Expenditures remained unchanged compare to the same period a year ago.

Anixa Biosciences Inc achieved highest trailing twelve month year on year Capital Expenditures growth. While overall Capital Expenditures growth ranking, remained unchanged compare to the previous quarter at no. .

Capital Expenditures TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Capital Expenditures TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Capital Expenditures TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Capital Expenditures Growth
Major Pharmaceutical Preparations Industry Capital Expenditures Growth Trends and Statistics
Healthcare Sector Capital Expenditures Growth Statistics
Capital Expenditures Growth Trends for overall market
ANIX's Capital Expenditures Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Capital Expenditures Growth
Lowest Ranking Capital Expenditures Growth
Capital Expenditures Growth for ANIX's Competitors
Capital Expenditures Growth for Anixa Biosciences Inc 's Suppliers
Capital Expenditures Growth for ANIX's Customers

You may also want to know
ANIX's Annual Growth Rates ANIX's Profitability Ratios ANIX's Asset Turnover Ratio ANIX's Dividend Growth
ANIX's Roe ANIX's Valuation Ratios ANIX's Financial Strength Ratios ANIX's Dividend Payout Ratio
ANIX's Roa ANIX's Inventory Turnover Ratio ANIX's Growth Rates ANIX's Dividend Comparisons



Companies with similar Capital Expenditures no change for the quarter ending Jan 31 2024 within Healthcare SectorY/Y Change %Capital Expenditures for the quarter ending Jan 31 2024
Kewaunee Scientific Corporation-26.13%$ -26.128 millions
Champions Oncology Inc -83.29%$ -83.289 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com